An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest

Clinical gynecologic endocrinology and infertility

Fritz, M. A., & Speroff, L. (1983) · Cited by 2,104 · see citing works

Arzneimittelforschung

(2017) · Arzneimittelforschung · doi:10.1055/s-00000175 · Cited by 1,134 · see citing works

Pharmacology of estrogens and progestogens: influence of different routes of administration

Kühl, H. (2005) · Climacteric · doi:10.1080/13697130500148875 · Cited by 835 · see citing works

Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of Drugs

Inman, W. H. W., Vessey, M. P., Westerholm, B., & Engelund, A. (1970) · BMJ · doi:10.1136/bmj.2.5703.203 · Cited by 609 · see citing works

The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation

Dinger, J. C., Heinemann, L. A. J., & Kühl-Habich, D. (2007) · Contraception · doi:10.1016/j.contraception.2006.12.019 · Cited by 472 · see citing works

New progestagens for contraceptive use

Sitruk-Ware, R. L. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi046 · Cited by 363 · see citing works

Comparison of pharmacodynamic properties of various estrogen formulations

Mashchak, C. A., Lobo, R. A., Dozono-Takano, R., Eggena, P., Nakamura, R. M., Brenner, P. F., & Mishell, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90218-6 · Cited by 316 · see citing works

Hormone Withdrawal Symptoms in Oral Contraceptive Users

Sulak, P. J., SCOW, R. D., Preece, C. K., Riggs, M. W., & Kuehl, T. J. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(99)00524-4 · Cited by 272 · see citing works

Shorter pill-free interval in combined oral contraceptives decreases follicular development

Spona, J., Elstein, M., Feichtinger, W., Sullivan, H. T., Lüdicke, F., Müller, U., & Düsterberg, B. (1996) · Contraception · doi:10.1016/0010-7824(96)00137-0 · Cited by 187 · see citing works

Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile

Sasagawa, S., Shimizu, Y., Kami, H., Takeuchi, T., Mita, S., Imada, K., Kato, S., & Mizuguchi, K. (2008) · Steroids · doi:10.1016/j.steroids.2007.10.003 · Cited by 177 · see citing works

Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone

Huber, J., Foidart, J., Wuttke, W., Merki‐Feld, G. S., The, H. S., Gerlinger, C., Schellschrmdt, I., & Heithecker, R. (2000) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180008500375 · Cited by 147 · see citing works

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel

Ahrendt, H.-J., Makalová, D., Parke, S., Mellinger, U., & Mansour, D. (2009) · Contraception · doi:10.1016/j.contraception.2009.03.018 · Cited by 147 · see citing works

Activated protein C resistance determined with a thrombin generation‐based test predicts for venous thrombosis in men and women

Tans, G., Vlieg, A. V. H., Thomassen, S., Curvers, J., Bertina, R. M., Rosing, J., & Rosendaal, F. R. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04443.x · Cited by 133 · see citing works

20 µg versus >20 µg estrogen combined oral contraceptives for contraception

Gallo, M. F., Nanda, K., Grimes, D. A., Lopez, L. M., & Schulz, K. F. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003989.pub5 · Cited by 133 · see citing works

Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive: A Randomized, Open-Label, Single-Centre Study

Junge, W., Mellinger, U., Parke, S., & Serrani, M. (2011) · Clinical Drug Investigation · doi:10.2165/11590220-000000000-00000 · Cited by 107 · see citing works

Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol

Alhenc‐Gelas, M., Thomas, J.-L., Bachelot‐Loza, C., Remones, V., Ali, F. D., Aiach, M., Scarabin, P., & Gaussem, P. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0327 · Cited by 101 · see citing works

Thromboembolic disease and the steroidal content of oral contraceptives.

Gi, S. (1970) · PubMed · Cited by 100 · see citing works

Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen

Klipping, C., Duijkers, I. J. M., Trummer, D., & Marr, J. (2008) · Contraception · doi:10.1016/j.contraception.2008.02.019 · Cited by 99 · see citing works

Pharmacokinetic and pharmacological features of oestradiol valerate

Düsterberg, B., & Nishino, Y. (1982) · Maturitas · doi:10.1016/0378-5122(82)90064-0 · Cited by 99 · see citing works

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive

Klipping, C., Duijkers, I. J. M., Parke, S., Mellinger, U., Serrani, M., & Junge, W. (2011) · Drugs in R&D · doi:10.2165/11591200-000000000-00000 · Cited by 92 · see citing works

New knowledge in the physiology of hormonal contraceptives

Løbo, R. A., & Stanczyk, F. Z. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)05011-8 · Cited by 88 · see citing works

Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): A Phase III trial

Palacios, S., Wildt, L., Parke, S., Machlitt, A., Römer, T., & Bitzer, J. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.11.001 · Cited by 85 · see citing works

Effect of four oral contraceptives on hemostatic parameters

Wiegratz, I., Lee, J. H., Kutschera, E., Winkler, U. H., & Kühl, H. (2004) · Contraception · doi:10.1016/j.contraception.2004.03.004 · Cited by 85 · see citing works

A Comparison between Effects of Estradiol Valerate and Low Dose Ethinyl Estradiol on Haemostasis Parameters

Lindberg, U.-B., Crona, N., Stigendal, L., Teger‐Nilsson, A. ‐., & Silfverstolpe, G. (1989) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646528 · Cited by 80 · see citing works

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies

Endrikat, J., Parke, S., Trummer, D., Schmidt, W., Duijkers, I. J. M., & Klipping, C. (2008) · Contraception · doi:10.1016/j.contraception.2008.05.004 · Cited by 77 · see citing works

Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest

Fraser, I. S., Parke, S., Mellinger, U., Machlitt, A., Serrani, M., & Jensen, J. T. (2011) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2011.591456 · Cited by 72 · see citing works

Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest

Zeun, S., Lu, M. Q., Uddin, A., Zeiler, B. N., Morrison, D., & Blode, H. (2009) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625180902850039 · Cited by 64 · see citing works

The pharmacological profile of dienogest

Oettel, M., Breitbarth, H., Elger, W., Gräser, T., Hübler, D., Kaufmann, G., Moore, C., Patchev, V., Römer, W., Schröder, J., et al. (1999) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189909085259 · Cited by 61 · see citing works

Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17 -estradiol (NOMAC/E2): a double-blind, randomized study

Christin‐Maître, S., Serfaty, D., Chabbert‐Buffet, N., Ochsenbein, E., Chassard, D., & Thomas, J. (2011) · Human Reproduction · doi:10.1093/humrep/der058 · Cited by 61 · see citing works

Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol.

Kuhnz, W., Gansau, C., & Mahler, M. (1993) · PubMed · Cited by 55 · see citing works

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol

Duijkers, I. J. M., Klipping, C., Grob, P. R., & Korver, T. (2010) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2010.504313 · Cited by 47 · see citing works

Pharmacokinetics of Exogenous Natural and Synthetic Estrogens and Antiestrogens

Kuhnz, W., Blode, H., & Zimmermann, H. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60107-1_15 · Cited by 46 · see citing works

A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene

Düsterberg, B., Ellman, H., Müller, U., Roive, E., & Mühe, B. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609041268 · Cited by 46 · see citing works

Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17β-estradiol

Wenzl, R. J., Bennink, H. J. T. C., van Beek, A., Spona, J., & Huber, J. C. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56210-4 · Cited by 45 · see citing works

A pharmacokinetic study with a low-dose oral contraceptive containing 20 μg ethinylestradiol plus 100 μg levonorgestrel

Endrikat, J., Blode, H., Gerlinger, C., Rosenbaum, P., & Kuhnz, W. (2002) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/ejc.7.2.79.90 · Cited by 45 · see citing works

Approaches to the replacement of ethinylestradiol by natural 17β-estradiol in combined oral contraceptives

Hoffmann, H., Moore, C., Zimmermann, H., Elger, W. A. G., Schwarz, S., Gräser, T., & Oettel, M. (1998) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(98)80034-1 · Cited by 43 · see citing works

A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens

Task Force on Oral Contraceptives, Koetsawang, S., Mandlekar, A., Krishna, U. R., Purandare, V. N., Deshpande, C. K., Chew, S. C., Fong, R., Ratnam, S. S., Kovács, L., et al. (1980) · Contraception · doi:10.1016/0010-7824(80)90010-4 · Cited by 42 · see citing works

Estrogen Replacement Therapy after the Menopause

Helgason, S. (1982) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348209155333 · Cited by 38 · see citing works

CLINICAL TRIAL OF A NEW ORAL CONTRACEPTIVE PILL CONTAINING THE NATURAL OESTROGEN 17β‐OESTRADIOL

Atedt, B., Jeppsson, S., Liedholm, P., Rannevik, G., & Svanberg, L. (1979) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1979.tb11276.x · Cited by 36 · see citing works

Oral contraceptive containing natural estradiol for premenopausal women

Hirvonen, E., Allonen, H. O., Anttila, M. P. V., Kulmala, Y., Ranta, T., Rautiainen, H., Sipilä, P., & Ylöstalo, P. (1995) · Maturitas · doi:10.1016/0378-5122(94)00856-3 · Cited by 33 · see citing works

Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: A double-blind, randomised, dose-finding pilot study

Chabbert‐Buffet, N., Chassard, D., Ochsenbein, E., Thomas, J.-L., & Christin‐Maître, S. (2011) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2011.554923 · Cited by 31 · see citing works

Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest

Spona, J., Feichtinger, W., Kindermann, C., Moore, C., Mellinger, U., Walter, F., & Gräser, T. (1997) · Contraception · doi:10.1016/s0010-7824(97)00123-6 · Cited by 29 · see citing works

NATURAL ŒSTROGENS FOR ORAL CONTRACEPTION

Serup, J. V., Bostofte, E., Larsen, S., Westergaard, J. H., & Lebech, P. E. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91525-3 · Cited by 29 · see citing works

Ovulation Inhibition with 17β‐Estradiol Cyclo‐Octyl Acetate and Desogestrel

Schubert, W., & Cullberg, G. (1987) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348709015732 · Cited by 28 · see citing works

New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women

Hirvonen, E., Stenman, U., Mälkönen, M., Rasi, V., Vartiainen, E., & Ylöstalo, P. (1988) · Maturitas · doi:10.1016/0378-5122(88)90023-0 · Cited by 25 · see citing works

The pharmacodynamic effects of an oral contraceptive containing 3 mg micronized 17β-estradiol and 0.150 mg desogestrel for 21 days, followed by 0.030 mg desogestrel only for 7 days

Csemiczky, G., Dieben, T. O. M., Bennink, H. J. T. C., & Landgren, B.-M. (1996) · Contraception · doi:10.1016/s0010-7824(96)00201-6 · Cited by 25 · see citing works

Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.

Serup, J. V., Bostofte, E., Larsen, S., & Westergaard, J. H. (1981) · PubMed · Cited by 23 · see citing works

THE COMPARATIVE EFFECTS OF A SYNTHETIC AND A‘NATURAL’ OESTROGEN ON THE HAEMOSTATIC MECHANISM IN PATIENTS WITH PRIMARY AMENORRHOEA

Toy, J., Davies, J. A., Hancock, K. W., & McNicol, G. P. (1978) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1978.tb14894.x · Cited by 23 · see citing works

Candesartan cilexetil: Development and preclinical studies

Gohlke, P. (1999) · Drugs of today · doi:10.1358/dot.1999.35.2.527966 · Cited by 21 · see citing works

20 µg versus >20 µg estrogen combined oral contraceptives for contraception

Gallo, M. F., Nanda, K., Grimes, D. A., Lopez, L. M., & Schulz, K. F. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003989.pub2 · Cited by 21 · see citing works

Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 µg/ ethinylestradiol 15 µg and a 21-day regimen of desogestrel 150 µg/ethinylestradiol 20 µg

Gestodene Study Group 324 (1999) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189909085266 · Cited by 20 · see citing works

EFFECTIVITY AND ACCEPTABILITY OF ORAL CONTRACEPTIVES CONTAINING NATURAL AND ARTIFICIAL ESTROGENS IN COMBINATION WITH A GESTAGEN

Serup, J. V., Bostofte, E., Larsen, S., & Westergaard, J. H. (1981) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.1981.tb00038.x · Cited by 18 · see citing works

SERUM LIPIDS AND LIPOPROTEINS DURING TREATMENT WITH ORAL CONTRACEPTIVES CONTAINING NATURAL AND SYNTHETIC OESTROGENS

Bostofte, E., Hemmingsen, L., Møller, K. J. A., Serup, J. V., & Weber, T. (1978) · European Journal of Endocrinology · doi:10.1530/acta.0.0870855 · Cited by 14 · see citing works

The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 µg and ethinylestradiol 15 µg

Gestodene Study Group 322 (1999) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189909085265 · Cited by 13 · see citing works

Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk

Morimont, L., Haguet, H., Dogné, J., GASPARD, U. J., & Douxfils, J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.769187 · Cited by 186 · see citing works

The structural biology of oestrogen metabolism

THOMAS, M. P., & Potter, B. V. L. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.12.014 · Cited by 181 · see citing works

Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern

Gooren, L. J., Wierckx, K., & Giltay, E. J. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0011 · Cited by 136 · see citing works

Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone

Klipping, C., Duijkers, I., Mawet, M., Maillard, C., Bastidas, A., Jost, M., & Foidart, J.-M. (2021) · Contraception · doi:10.1016/j.contraception.2021.01.001 · Cited by 108 · see citing works

Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol

Kluft, C., Zimmerman, Y., Mawet, M., Klipping, C., Duijkers, I. J. M., Neuteboom, J., Foidart, J.-M., & Bennink, H. C. (2017) · Contraception · doi:10.1016/j.contraception.2016.08.018 · Cited by 94 · see citing works

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia

Gemzell‐Danielsson, K., Apter, D. L., Zatik, J., Weyers, S., Piltonen, T., Сутурина, Л. В., Анатольевна, А. И., Jost, M., Creinin, M. D., & Foidart, J. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16840 · Cited by 83 · see citing works

Choosing a combined oral contraceptive pill

Stewart, M., & Black, K. I. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.002 · Cited by 53 · see citing works

Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations

Cattoni, A., Parissone, F., Porcari, I., Molinari, S., Masera, N., Franchi, M. P., Cesaro, S., Gaudino, R., Passoni, P., & Balduzzi, A. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100730 · Cited by 51 · see citing works

A novel estetrol-containing combined oral contraceptive: European expert panel review

Gemzell‐Danielsson, K., Cagnacci, A., Chabbert‐Buffet, N., Douxfils, J., Foidart, J., Kubba, A., Lete, I., Mansour, D., Neulen, J., Neves, J., et al. (2022) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2022.2093850 · Cited by 47 · see citing works

Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies

Mendoza, N., Simoncini, T., & Genazzani, A. D. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.943725 · Cited by 38 · see citing works

Discontinuation of modern hormonal contraceptives: an Italian survey

Fruzzetti, F., Perini, D., Fornaciari, L., Russo, M., Bucci, F., & Gadducci, A. (2016) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2016.1234598 · Cited by 38 · see citing works

Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women

Kaunitz, A. M., Achilles, S. L., Zatik, J., Weyers, S., Piltonen, T., Сутурина, Л. В., Анатольевна, А. И., Bouchard, C., Chen, M. J., Jensen, J. T., et al. (2022) · Contraception · doi:10.1016/j.contraception.2022.07.010 · Cited by 28 · see citing works

Venous Thromboembolic Risk of Estradiol Valerate–Dienogest Compared with Ethinyl Estradiol–Levonorgestrel Combined Oral Contraceptives

Bauerfeind, A., von Stockum, S., Boehnke, T., & Heinemann, K. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005509 · Cited by 26 · see citing works

The Chronobiology of Hormone Administration: “Doctor, What Time Should I Take My Medication?”

Colonnello, E., Graziani, A., Rossetti, R., Voltan, G., Masi, D., Lubrano, C., Mariani, S., Watanabe, M., Isidori, A. M., Ferlin, A., et al. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf013 · Cited by 23 · see citing works

Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4)

Creinin, M. D., Cagnacci, A., Spaczyński, R., Stute, P., Chabbert‐Buffet, N., Korver, T., & Simoncini, T. (2024) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2024.1395863 · Cited by 21 · see citing works

Contraceptive counselling and self-prescription of contraceptives of German gynaecologists: Results of a nationwide survey

Bühling, K. J., Klovekorn, L., Daniels, B., von Studnitz, F. S. G., Eulenburg, C., & Mueck, A. O. (2014) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2014.945164 · Cited by 16 · see citing works

Contraception for midlife women: a review

Miller, T. A., Allen, R. H., Kaunitz, A. M., & Cwiak, C. A. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001073 · Cited by 16 · see citing works

Overview of perimenopausal contraception

Bitzer, J. (2018) · Climacteric · doi:10.1080/13697137.2018.1540566 · Cited by 14 · see citing works

A technology evaluation of Annovera: a segesterone acetate and ethinyl estradiol vaginal ring used to prevent pregnancy for up to one year

Micks, E., & Jensen, J. T. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1764529 · Cited by 12 · see citing works

Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under

Jensen, J. T., Bitzer, J., Nappi, R. E., Ahlers, C., Bannemerschult, R., & Parke, S. (2020) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2020.1731734 · Cited by 12 · see citing works

An Improved Synthesis of Nomegestrol Acetate

Lu, H.-L., Wu, Z., Song, S., Liao, X.-D., Zhu, Y., & Huang, Y. (2014) · Organic Process Research & Development · doi:10.1021/op4003533 · Cited by 11 · see citing works

NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study

von Stockum, S., Becker, K., Bauerfeind, A., Franke, C., Fruzzetti, F., Calaf, J., Keck, C., & Heinemann, K. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2166032 · Cited by 9 · see citing works

Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?

Tiranini, L., Cucinella, L., Martella, S., Bosoni, D., Martini, E., & Nappi, R. E. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2198705 · Cited by 7 · see citing works

Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen

SHULMAN, L. P. (2013) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2013-100605 · Cited by 6 · see citing works

An update on new orally administered contraceptives for women

Nelson, A. L. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1100173 · Cited by 5 · see citing works

Hormonelle Kontrazeption mit östradiolhaltigen Kombinationspräparaten

Foth, D., Römer, T., & Ahrendt, H.-J. (2013) · Gynäkologische Endokrinologie · doi:10.1007/s10304-012-0530-6 · Cited by 5 · see citing works

Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland

Sutherland, C. S., Ademi, Z., Michaud, J., Schur, N., Lingg, M., Bhadhuri, A., Pache, T. D., Bitzer, J., Suchon, P., Albert, V., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031325 · Cited by 4 · see citing works

Developments in contraception

Weisberg, E. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.862234 · Cited by 4 · see citing works

Continuous Use of Combined Hormonal Contraceptive and the Effect on Blood Coagulation Factors in Female Capuchin Monkeys (Sapajus libidinosus)

Rodrigues, R. C., Belham, F. S., Garcia, A., Satler, C. E., Tomaz, C. A. B., & Tavares, M. C. H. (2019) · International Journal of Endocrinology · doi:10.1155/2019/2047803 · Cited by 4 · see citing works

Thromboembolic safety profile of low-dose estradiol (valerate) in combined hormonal preparations: Implications for the development of new hormonal endometriosis and uterine fibroid therapies

Barnett, C., Bauerfeind, A., von Stockum, S., & Heinemann, K. (2021) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.1177/22840265211019546 · Cited by 3 · see citing works

Hormonal Contraception and Bone

Birkhaeuser, M. H. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-70932-7_21 · Cited by 3 · see citing works

Saúde cardiovascular da mulher – Documento de Consenso da Sociedade Portuguesa de Cardiologia, Sociedade Portuguesa de Ginecologia, Sociedade Portuguesa de Obstetrícia e Medicina Materno‐Fetal, Sociedade Portuguesa de Contraceção e Associação Portuguesa de Medicina Geral e Familiar

Timóteo, A. T., Ribeiras, R., Calé, R., Moura, B., Almeida, A. G., Gavina, C., Cabral, S., António, N., Franco, F., Moreira, R. I., et al. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2022.12.013 · Cited by 3 · see citing works

Sex Hormones and Related Compounds, Including Hormonal Contraceptives

Millán, M. M., & Castañeda, S. (2014) · Side effects of drugs annual · doi:10.1016/b978-0-444-63407-8.00040-x · Cited by 2 · see citing works

Failure from the previously selected method of contraception and strategy for improving commitment

Дикке, Г. Б. (2017) · Russian Journal of Human Reproduction · doi:10.17116/repro201723554-60 · Cited by 2 · see citing works

Contraception: A Casebook from Menarche to Menopause

(2015) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12166 · Cited by 2 · see citing works

Training and hormones in physically active women : with and without oral contraceptive use

Wikström-Frisén, L. (2016) · DiVA at Umeå University (Umeå University) · Cited by 2 · see citing works

Family Planning

Paoletti, A. M., Melis, G. B., Piras, B., Pilloni, M., Zedda, P., Marotto, M. F., Vallerino, V., Melis, A., Taccori, V., Melis, V., et al. (2024) · Obstetrics and gynecology. · doi:10.5772/intechopen.111643 · Cited by 1 · see citing works

Contraception for adolescent and young women. A consensus conference results

Fruzzetti, F., Cagnacci, A., Farris, M., Dei, M., Caruso, S., Fidecicchi, T., Paolo, G. D., Londero, A. P., & for the Italian Society of Contraception (S.I.C.) (2025) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2025.2586091 · Cited by 1 · see citing works

Combined Oral Contraceptive Use at the University of Port Harcourt Teaching Hospital, Port Harcourt, Southern Nigeria: A-20 Year Review

Ojule, J. D., & Oranu, E. O. (2017) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2017.56002 · Cited by 1 · see citing works

New developments in oral contraception: clinical utility of estradiol valerate/dienogest (Natazia®) for contraception and for treatment of heavy menstrual bleeding: patient considerations

Nelson, A. L. (2012) · Open Access Journal of Contraception · doi:10.2147/oajc.s26225 · Cited by 1 · see citing works

How to reduce the number of side effects produced by COCs and improve adherence: simple tips for practitioners

Дикке, Г. Б. (2016) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2016-2-10-13 · Cited by 1 · see citing works

RISCO DE DOENÇA TROMBOLÍTICAS APÓS O USO DE ALGESTONA ACETOFENIDA E ENANTATO DE ESTRADIOL

Duarte, R. C. R., Belham, F. S., & Tavares, M. C. H. (2018) · Revista de Patologia do Tocantins · doi:10.20873/uft.2446-6492.2018v5n1p17 · Cited by 1 · see citing works

Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: Practical recommendations.

Cattoni, A., Parissone, F., Porcari, I., Molinari, S., Masera, N., Franchi, M. P., Cesaro, S., Gaudino, R., Passoni, P., & Balduzzi, A. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.9.7 · Cited by 1 · see citing works

Theoestrogen component of currently used steroidal contraceptives

Crook, D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781107323469.007

The Best Prophet of the Future is the Past: Oral Contraception and Novel Components

SHULMAN, L. P. (2014) · Journal of Women s Health · doi:10.1089/jwh.2014.4733

Individualizing Selection of Hormonal Contraception

Raney, E. C., Scott, S. C., & Cauthon, K. A. B. (2014) · Osteopathic Family Physician · doi:10.1016/ofp.v6i4.338

Avaliação de formulações contraceptivas por parâmetros hemostáticos, vasoativos e inflamatórios em cultura de células endoteliais humanas

Amaral, D. S. (2015) · doi:10.11606/d.60.2015.tde-25092015-143858

Efeitos do tratamento prolongado de testosterona associado ao uso de algestona acetofenida e enantato de estradiol sobre o ciclo menstrual de fêmeas cativas de Sapajus libidinosus (macaco-prego)

Rodrigues, R. C. (2016) · doi:10.26512/2016.08.t.22178

Real clinical practice and contraception for young women with children

Aganezova, N. V., & Станиславович, А. С. (2021) · GYNECOLOGY · doi:10.26442/20795696.2021.1.200629

A combined injectable contraceptive improves plasma redox status and does not induce vascular changes in female rats

NERY, L. C. D. E. S., BRAZ, L. C. S., Ferreira, L. L. D. M., VIEIRA, F. P., da Silva, L. L., Blanc, H. N. H., & Raimundo, J. M. (2021) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202120201924 · Cited by 1 · see citing works

Treatments

Stracquadanio, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-29223-2_4

Optimizing oral contraceptive timing: Daytime intake reduces doses and enhances efficacy

Gavina, B. L. A., Lee, T., Cawiding, O. R., Choi, S., Choi, S., Kim, S., & Kim, J. K. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1014040

Family Planning

Paoletti, A. M., Melis, G. B., Piras, B., Pilloni, M., Zedda, P., Marotto, M. F., Vallerino, V., Melis, A., Taccori, V., Giancane, E., et al. (2026) · Springer eBooks · doi:10.1007/978-3-032-05381-7_75

Aspectos práticos quanto à escolha do contraceptivo oral combinado

Machado, R. B., MONTEIRO, I. M. U., Brito, M. B., & Lubianca, J. N. (2021) · Femina · doi:10.61622/0100-725449902101

Algorithm for prescribing hormonal contraception and menopausal hormone therapy in perimenopause

Baranov, I. I., Andreeva, E. N., Yureneva, S. V., Yarmolinskaya, M. I., Balan, V. E., Ивановна, А. Е., Aganezova, N. V., Bezhenar, V. F., Густоварова, Т. А., Dobrokhotova, J. E., et al. (2026) · Bulletin of Reproductive Health · doi:10.14341/brh12801

Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol

Jensen, J. T., Bitzer, J., & Serrani, M. (2013) · Open Access Journal of Contraception · doi:10.2147/oajc.s50693 · Cited by 6 · see citing works

Estradiol Valerate/Dienogest: A Novel Combined Oral Contraceptive

Borgelt, L. M., & Martell, C. W. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.006 · Cited by 32 · see citing works

Review of clinical experience with estradiol in combined oral contraceptives

Fruzzetti, F., & Bitzer, J. (2009) · Contraception · doi:10.1016/j.contraception.2009.08.010 · Cited by 56 · see citing works

Natural estrogens: the new reference in contraception. An Italian expert opinion paper

Cagnacci, A., Lello, S., Capozzi, A., & Simoncini, T. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2725109

Comparison of estrogenic components used for hormonal contraception

Stanczyk, F. Z., Winer, S. A., Foidart, J., & Archer, D. F. (2023) · Contraception · doi:10.1016/j.contraception.2023.110310 · Cited by 54 · see citing works